James Stephen Ewing was an American pathologist. He was the first Professor of pathology at Cornell University and discovered a form of bone cancer that was later named after him, Ewing sarcoma.
Memorial Sloan Kettering Cancer Center is a cancer treatment and research institution in Manhattan in New York City. It was founded in 1884 as the New York Cancer Hospital. MSKCC is one of 72 National Cancer Institute-designated Comprehensive Cancer Centers. It had already been renamed and relocated, to its present site, when the Sloan-Kettering Institute for Cancer Research was founded in 1945, and built adjacent to the hospital. The two medical entities formally coordinated their operations in 1960, and formally merged as a single entity in 1980. Its main campus is located at 1275 York Avenue between 67th and 68th Streets in Manhattan.
The New York Cancer Hospital (NYCH) on the Upper West Side of Manhattan, New York City was a cancer treatment and research institution founded in 1884. The building was located at 455 Central Park West between West 105th and 106th Streets, and built between 1884 and 1886 with additions made between 1889 and 1890; it was designed by Charles Coolidge Haight in the Late Gothic and French Chateau styles – inspired by the chateaux of the Loire Valley. It was the first hospital in the United States dedicated specifically for the treatment of cancer, and the second in the world after the London Cancer Hospital. After outgrowing the original building and moving, it became what is today known as Memorial Sloan-Kettering Cancer Center.
The Weill Cornell Graduate School of Medical Sciences (WCGS), formerly known as the Cornell University Graduate School of Medical Sciences, is a graduate college of Cornell University that was founded in 1952 as an academic partnership between two major medical institutions in New York City: Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center. Cornell is involved in the Tri-Institutional MD–PhD Program with Rockefeller University and the Sloan Kettering Institute; each of these three institutions is part of a large biomedical center extending along York Avenue between 65th and 72nd Streets on the Upper East Side of Manhattan.
Maimonides Medical Center is a non-profit, non-sectarian hospital located in Borough Park, in the New York City borough of Brooklyn, in the U.S. state of New York. Maimonides is both a treatment facility and academic medical center with 711 beds, and more than 70 primary care and sub-specialty programs. As of August 1, 2016, Maimonides Medical Center was an adult and pediatric trauma center, and Brooklyn's only pediatric trauma center.
The Joan & Sanford I. Weill Medical College of Cornell University is Cornell University's biomedical research unit and medical school in New York City.
Josep Baselga i Torres, known in Spanish as José Baselga, was a Spanish medical oncologist and researcher focused on the development of novel molecular targeted agents, with a special emphasis in breast cancer. Through his career he was associated with the Memorial Sloan Kettering Cancer Center, Vall d'Hebron Institute of Oncology, and the Massachusetts General Hospital in their hematology and oncology divisions. He led the development of the breast cancer treatment Herceptin, a monoclonal antibody, that targets the HER2 protein, which is impacted in aggressive breast cancers.
Cornelius Packard "Dusty" Rhoads was an American pathologist, oncologist, and hospital administrator who was involved in a racist scandal and subsequent whitewashing in the 1930s. Beginning in 1940, he served as director of Memorial Hospital for Cancer Research in New York, from 1945 was the first director of Sloan-Kettering Institute, and the first director of the combined Memorial Sloan–Kettering Cancer Center. For his contributions to cancer research, Rhoads was featured on the cover of the June 27, 1949 issue of Time magazine under the title "Cancer Fighter".
William S. Breitbart, FAPM, is an American psychiatrist in Psychosomatic Medicine, Psycho-oncology, and Palliative Care. He is the Jimmie C Holland Chair in Psychiatric Oncology, and the Chief of the Psychiatry Service, Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, He is a Professor of Clinical Psychiatry at Weill Medical College of Cornell University. He was president of the Academy of Psychosomatic Medicine, and the Editor-in-Chief of Palliative and Supportive Care.
Cabrini Medical Center of New York City was created in 1973 by a merger of two Manhattan hospitals. It closed in 2008 due to financial difficulties cited by the Berger Commission, followed by a bankruptcy filing.
George Bosl is an American cancer researcher, holder of the Patrick M. Byrne Chair in Clinical Oncology at the Memorial Sloan-Kettering Cancer Center in New York City, and is a professor of medicine at the Weill Cornell Medical College. In 1997, he was appointed chair of the Department of Medicine at Sloan-Kettering, a position which he held until 2015. In 2019, he was named Memorial Sloan Kettering's first ombudsperson.
James Gerald Hirsch was an American physician and biomedical researcher who specialized in immunology. Hirsch was also notable for his studies of phagocyte.
John H. Healey is an American cancer surgeon, researcher, and expert in the surgical treatment of benign and malignant bone tumors and other musculoskeletal cancers. He serves as Chair of the Orthopaedic Service and Stephen P. McDermott Chair in Surgery at Memorial Sloan-Kettering Cancer Center (MSKCC), as well as Professor of Surgery at Weill Cornell Medical College, in New York, NY.
Peter B. Bach is a physician and writer in New York City. He is the Chief Medical Officer of DELFI Diagnostics and was previously an attending and researcher at Memorial Sloan-Kettering Cancer Center where he was the Director of the Center for Health Policy and Outcomes. His research focuses on healthcare policy, particularly as it relates to Medicare, racial disparities in cancer care quality, and lung cancer. Along with his scientific writings he is a frequent contributor to The New York Times and other newspapers.
Paul Alan Marks was a medical doctor, researcher and administrator. He was a faculty member and president at Memorial Sloan Kettering Cancer Center.
Jack E. White was an American physician and cancer surgeon. He was the first black physician to train in surgical oncology at Memorial Sloan Kettering Cancer Center. White later directed the cancer center at Howard University College of Medicine where he also served as a full professor. He was elected to the Institute of Medicine in 1977 and he served as president of the American Cancer Society.
Jimmie Coker Holland was a founder of the field of psycho-oncology. In 1977, she worked with two colleagues to establish a full-time psychiatric service at Memorial Sloan Kettering Cancer Center. The program was one of the first of its kind in cancer treatment, and trained its psychologists to specialize in issues specific to people with cancer.
Dr. Kathleen M. Foley is an American physician. She was an Attending Neurologist at Memorial Sloan-Kettering Cancer Center in New York City. She worked as a professor of Neurology, Neuroscience, and Clinical Pharmacology at Cornell University Weill Medical College. Foley made contributions toward making palliative care for cancer patients accessible. She headed the country's first pain service in a cancer center at Memorial Sloan-Kettering and was the medical director of the Supportive Care Program. In 1999, she became the director of the Open Society Institute’s Project on Death in America. Additionally, Foley was the Director of the WHO Collaborating Center for Cancer Pain Research and Education at Memorial Sloan-Kettering Cancer Center. She holds the Chair of the Society of Memorial Sloan-Kettering Cancer Center in Pain Research and continues to work with the Open Society Institute as the Medical Director of the International Palliative Care Initiative of the Network Public Health Program of the Research.
Lisa Marie DeAngelis is an American neuro-oncologist and Physician-in-Chief and Chief Medical Officer at Memorial Sloan Kettering Cancer Center.
